Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform

Summary

Autonomix Medical received issuance of U.S. Patent No. 12,471,776 covering ANS Assessment Systems, Kits, and Methods for monitoring physiologic signals to assess autonomic nervous system activity. The patent supports patient selection, procedural guidance, treatment feedback, and post-treatment monitoring across neuromodulation applications. It expands the company’s intellectual property for precision nerve-targeted therapies of the peripheral nervous system.